3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
3
Terminated
2
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
29
Thoracic
1
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
549
Lung Neoplasms
312
Small Cell Lung Carcinoma
86
Colorectal Neoplasms
71
Melanoma
68
Breast Neoplasms
60
Neoplasms
55
Ovarian Neoplasms
47
Carcinoma, Renal Cell
45
Neoplasm Metastasis
44
Squamous Cell Carcinoma of Head and Neck
42
Pancreatic Neoplasms
39
Stomach Neoplasms
37
Triple Negative Breast Neoplasms
30
Head and Neck Neoplasms
30
Esophageal Neoplasms
28
Endometrial Neoplasms
25
Prostatic Neoplasms
24
Uterine Cervical Neoplasms
23
Urinary Bladder Neoplasms
23
Brain Neoplasms
22
Mesothelioma
21
Colonic Neoplasms
21
Mesothelioma, Malignant
19
Carcinoma, Hepatocellular
18
Sarcoma
16
Carcinoma, Transitional Cell
15
Adenocarcinoma of Lung
15
Lung Diseases
14
NSCLC
13
Interventions
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Advanced Solid Tumor
×
Thoracic
×
Clear all
NCT05117476
2025-11-24
MICA
Cullinan Therapeutics Inc.
Phase 1
Active not recruiting
440 enrolled